Ichthyosis Vulgaris
Ichthyosis
Ichthyosis, Lamellar
Pycnodysostosis
Intermediate Filament Proteins
Maxillofacial Abnormalities
Cranial Fontanelles
Ichthyosis, X-Linked
Dermatitis, Atopic
Ichthyosiform Erythroderma, Congenital
Proteus vulgaris
Skin
Steryl-Sulfatase
Desulfovibrio vulgaris
Hyperkeratosis, Epidermolytic
Loss of normal profilaggrin and filaggrin in flaky tail (ft/ft) mice: an animal model for the filaggrin-deficient skin disease ichthyosis vulgaris. (1/27)
Flaky tail (gene symbol ft) is an autosomal recessive mutation in mice that results in a dry, flaky skin, and annular tail and paw constrictions in the neonatal period. Previous studies demonstrated that the ft mutation maps to the central region of mouse chromosome 3, in the vicinity of the epidermal differentiation complex, a gene locus that includes many nonkeratin genes expressed in epidermis. In this study we report a detailed characterization of the flaky tail mouse. Affected homozygous ft/ft mice exhibit large, disorganized scales on tail and paw skin, marked attenuation of the epidermal granular layer, mild acanthosis, and orthokeratotic hyperkeratosis. Biochemical analysis demonstrated that ft/ft mice lacked normal high molecular profilaggrin (approximately 500 kDa), and instead expressed a lower molecular weight form of profilaggrin (220 kDa) that is not proteolytically processed to profilaggrin intermediates or filaggrin. Mutant mice lacked the large, irregular F-type keratohyalin granules that contain profilaggrin, and filaggrin was absent from the cornified layers of ft/ft epidermis. The expression of epidermal keratins was unchanged, whereas the cornified envelope proteins involucrin and loricrin were increased in ft/ft epidermis. Cultured ft/ft keratinocytes also synthesized reduced amounts of profilaggrin mRNA and protein, demonstrating that the defect in profilaggrin expression is intrinsic to epidermal cells. These findings demonstrate that flaky tail mice express an abnormal profilaggrin polypeptide that does not form normal keratohyalin F-granules and is not proteolytically processed to filaggrin. We propose that the absence of filaggrin, and in particular the hygroscopic, filaggrin-derived amino acids that are thought to function in epidermal hydration, underlies the dry, scaly skin characteristic of ft/ft mice. This animal model provides a tool for understanding the role of filaggrin in normal epidermal function and may provide insight into the molecular basis of the filaggrin-deficient human skin disorder ichthyosis vulgaris. J Invest Dermatol 115:1072-1081 2000 (+info)Deletion of exons 1-5 of the STS gene causing X-linked ichthyosis. (2/27)
X-linked ichthyosis is an inherited disorder due to steroid sulfatase deficiency. It is clinically characterized by dark, adhesive, and regular scales of the skin. Most X-linked ichthyosis patients present large deletions of the STS gene and flanking markers; a minority show a point mutation or partial deletion of the STS gene. In this study we analyzed the STS gene in a family with simultaneous occurrence of X-linked ichthyosis and ichthyosis vulgaris. X-linked ichthyosis diagnosis was confirmed through steroid sulfatase assay in leukocytes using 7-[3H]-dehydroepiandrosterone sulfate as a substrate. Exons 1, 2, 5, and 6-10, and the 5' flanking markers DXS1130, DXS1139, and DXS996 of the STS gene were analyzed by polymerase chain reaction. X-linked ichthyosis patients of the family (n = 4 males) had undetectable levels of STS activity (0.00 pmol per mg protein per h). The DNA analysis showed that only exons 6-10 and the 5' flanking markers of the STS gene were present. We report the first partial deletion of the STS gene spanning exons 1-5 in X-linked ichthyosis patients. (+info)Epidermal tight junctions: ZO-1 and occludin are expressed in mature, developing, and affected skin and in vitro differentiating keratinocytes. (3/27)
This study demonstrates the presence of tight junction antigens in adult and developing human epidermis. Indirect immunofluorescence labeling and immunoelectron microscopy with antibodies to ZO-1 and occludin localized tight junction components ZO-1 and occludin to a narrow zone of the granular cells of adult epidermis. Double immunolabeling for tight junction components with adherens junction or desmosome proteins suggested that occludin is more specific for tight junctions than ZO-1, which may also be associated with adherens junctions. In developing skin, tight junctions interconnected the peridermal cells, and after the fetal stratification localized to the granular cell layer. Immunolabeling of psoriasis, lichen planus, and ichthyosis vulgaris, representing aberrant differentiation of the epidermis, showed that these conditions were associated with relocation of ZO-1 and occludin to the spinous cells. Cultures of epidermal keratinocytes, which offer a useful model for the formation of cellular contacts, revealed that tight junction components, ZO-1 and occludin, displayed a marked degree of colocalization relatively late during the process when the fusion zone had assumed a linear appearance. This suggests that the formation of adherens junctions and desmosomes precedes that of tight junctions. We speculate that the epidermal barrier, isolating the human body from the external environment, is in part formed by tight junctions of stratum granulosum. (+info)Expression of transglutaminase 5 in normal and pathologic human epidermis. (4/27)
To explore the expression and gain more information on the function of transglutaminase 5 enzyme in normal and defective human epidermis, we generated a rat antihuman transglutaminase 5 antiserum elicited against a purified active recombinant protein expressed in the baculovirus system. By use of Western blotting and immunofluorescence methods, the immunospecificity of the antibodies for transglutaminase 5 was tested; no crossreactivity with other transglutaminases (types 1, 2, and 3) was observed, thus allowing histochemistry studies. By indirect immunofluorescence analysis the antibodies decorated the upper layers of normal human epidermis, with consistent staining in the spinous and granular layers. We evaluated transglutaminase 5 expression in comparison with proliferating (keratin 14) and differentiating (transglutaminase 3) markers in different diseases, such as psoriasis, ichthyosis vulgaris, lamellar ichthyosis, and Darier's disease. We observed that transglutaminase 5 contributes, as a secondary effect, to the hyperkeratotic phenotype in ichthyosis (both vulgaris and lamellar) and in psoriasis. In Darier's disease, transglutaminase 5 expression, as well as transglutaminase 3, is completely missregulated, being overexpressed or totally absent in different areas of the same lesion. (+info)Epidermal differentiation complex yields a secret: mutations in the cornification protein filaggrin underlie ichthyosis vulgaris. (5/27)
Ichthyosis vulgaris (IV), characterized by mild scaling on limbs and lower abdomen, has an incidence of 1 in 250. Smith, McLean, and colleagues demonstrate that common mutations in filaggrin underlie IV. Filaggrin aggregates keratin intermediate filaments and is cross-linked into the cornified envelope to form the epidermal barrier. These findings reinforce the importance of the epidermal barrier in pathogenesis of skin diseases. (+info)Prevalent and rare mutations in the gene encoding filaggrin cause ichthyosis vulgaris and predispose individuals to atopic dermatitis. (6/27)
Mutations in the filament aggregating protein (filaggrin) gene have recently been identified as the cause of the common genetic skin disorder ichthyosis vulgaris (IV), the most prevalent inherited disorder of keratinization. The main characteristics of IV are fine-scale on the arms and legs, palmar hyperlinearity, and keratosis pilaris. Here, we have studied six Irish families with IV for mutations in filaggrin. We have identified a new mutation, 3702delG, in addition to further instances of the reported mutations R501X and 2282del4, which are common in people of European origin. A case of a 2282del4 homozygote was also identified. Mutation 3702delG terminates protein translation in filaggrin repeat domain 3, whereas both recurrent mutations occur in repeat 1. These mutations are semidominant: heterozygotes have an intermediate phenotype most readily identified by palmar hyperlinearity and in some cases fine-scale and/or keratosis pilaris, whereas homozygotes or compound heterozygotes generally have more marked ichthyosis. Interestingly, the phenotypes of individuals homozygous for R501X, 2282del4, or compound heterozygous for R501X and 3702delG, were comparable, suggesting that mutations located centrally in the filaggrin repeats are also pathogenic. (+info)Filaggrin mutations p.R501X and c.2282del4 in ichthyosis vulgaris. (7/27)
Ichthyosis vulgaris (IV) is the most common hereditary disorder of cornification in humans, characterized by generalized fine scaling of the skin, palmar hyperlinearity with or without keratosis pilaris and atopy. Recently, the molecular basis of IV was ascribed to loss-of-function mutations in the gene encoding filaggrin (FLG), namely p.R501X and c.2282del4. Homozygotes and compound heterozygotes were severely affected whereas heterozygotes showed mild disease or were asymptomatic, suggesting semidominant inheritance with incomplete penetrance in heterozygotes. We report the presence of FLG mutations in 15 out of 21 IV patients with a marked generalized scaling phenotype, including eight affected members of a four-generation family. In this group of patients not only homozygous and compound heterozygous, but also heterozygous patients for p.R501X and c.2282del4 display a pronounced phenotype, whereas in none of six individuals these two mutations were detectable despite decreased filaggrin expression on immunohistochemistry in two patients, indicating that other mutations in FLG and/or in other genes remain to be identified. In contrast, two additional p.R501X heterozygotes from the extended family are asymptomatic. In a control population from west-Austria a combined p.R501X and c.2282del4 carrier frequency of 6/110 (5.45%) was observed. We confirm that these FLG variants are common, but our results point to the existence of additional modifiers. (+info)Loss-of-function mutations in the filaggrin gene and allergic contact sensitization to nickel. (8/27)
Allergic contact dermatitis is one of the most frequent dermatological problems affecting 7% of the general population. Impaired skin barrier function facilitates the penetration of contact allergens and irritants into the epidermal layer and is regarded as an important cofactor promoting the process of allergic contact sensitization. Filaggrin is crucial for the maintenance of the skin barrier function. Loss-of-function mutations within the filaggrin (FLG) gene are associated with skin barrier diseases such as ichthyosis vulgaris and atopic eczema (AE). To assess the impact of FLG on allergic contact sensitization and plausible intermediate traits, the two prevalent FLG mutations R501X and 2282del4 were typed in 1,502 individuals of the KORA C population-based cohort with extensive dermatologic phenotyping. Associations of FLG mutations with AE could be replicated. Strong associations were seen with dry skin, palmar hyperlinearity, and keratosis pilaris. In addition, an association with contact sensitization to nickel and contact sensitization to nickel combined with intolerance to fashion jewelry, but not with other contact allergens, was observed. From these data, we conclude that a genetically determined FLG deficiency manifests as dry skin and features of ichthyosis vulgaris. In addition, FLG deficiency may also represent a risk factor for contact sensitization to allergens. (+info)Ichthyosis Vulgaris is a genetic skin disorder, which is characterized by dry, scaly, and rough skin. It is one of the most common forms of ichthyosis and is usually inherited in an autosomal dominant pattern, meaning only one copy of the altered gene in each cell is sufficient to cause the condition.
The term "ichthyosis" comes from the Greek word "ichthys," which means fish, reflecting the scaly appearance of the skin in individuals with this disorder.
In people with Ichthyosis Vulgaris, the skin cells do not shed properly and instead, they accumulate in scales on the surface of the skin. These scales are typically small, white to grayish-brown, and polygonal in shape. The scales are most often found on the legs, arms, and trunk but can affect any part of the body.
The condition usually appears during early childhood and tends to get worse in dry weather. In many cases, it improves during adulthood, although the skin remains rough and scaly.
Ichthyosis Vulgaris is caused by mutations in the gene called filaggrin, which is responsible for maintaining a healthy barrier function in the skin. This leads to dryness and increased susceptibility to skin infections.
Ichthyosis is a group of skin disorders that are characterized by dry, thickened, scaly skin. The name "ichthyosis" comes from the Greek word "ichthys," which means fish, as the skin can have a fish-like scale appearance. These conditions can be inherited or acquired and vary in severity.
The medical definition of ichthyosis is a heterogeneous group of genetic keratinization disorders that result in dry, thickened, and scaly skin. The condition may affect any part of the body, but it most commonly appears on the extremities, scalp, and trunk. Ichthyosis can also have associated symptoms such as redness, itching, and blistering.
The severity of ichthyosis can range from mild to severe, and some forms of the condition may be life-threatening in infancy. The exact symptoms and their severity depend on the specific type of ichthyosis a person has. Treatment for ichthyosis typically involves moisturizing the skin, avoiding irritants, and using medications to help control scaling and inflammation.
Lamellar Ichthyosis is a rare, inherited genetic skin disorder characterized by widespread, persistent scaling of the skin. It is caused by mutations in genes responsible for maintaining the barrier function and hydration of the skin. The condition is present from birth and can vary in severity.
In lamellar ichthyosis, the skin cells do not shed properly and instead accumulate in plates or scales that cover the entire body. These scales are large, dark brown or gray, and have a cracked appearance, resembling fish scales. The scales may be present at birth (congenital) or develop within the first few weeks of life.
The skin is also prone to redness, irritation, and infection due to the impaired barrier function. Other symptoms can include overheating, dehydration, and difficulty with sweating. The condition may improve in warmer, more humid environments.
Treatment for lamellar ichthyosis is aimed at managing symptoms and preventing complications. This may include topical creams and ointments to moisturize the skin, medications to reduce inflammation and infection, and avoiding environmental triggers that can worsen symptoms. In some cases, oral retinoids may be prescribed to help regulate skin cell growth and shedding.
Pycnodysostosis is a rare genetic disorder characterized by skeletal dysplasia (abnormal development of the bones) and distinctive facial features. The condition is caused by mutations in the CTSK gene, which provides instructions for making an enzyme called cathepsin K. This enzyme is responsible for breaking down collagen, a protein that provides structure and strength to connective tissues throughout the body.
In people with pycnodysostosis, the lack of functional cathepsin K leads to the accumulation of abnormal bone matrix, which results in bones that are dense but fragile and prone to fractures. The condition is also associated with a number of other skeletal abnormalities, including:
* Short stature
* A prominent forehead (frontal bossing)
* A broad, flat nasal bridge
* A small chin (micrognathia)
* A narrow mouth
* A high-arched palate
* Dental abnormalities, such as delayed tooth eruption and thickened dental enamel
* Hypoplastic or aplastic clavicles (collarbones)
* Short fingers and toes
* Multiple fractures, particularly in the long bones of the arms and legs
Pycnodysostosis is typically diagnosed in childhood based on clinical features and confirmed with genetic testing. There is no cure for the condition, but treatment is focused on managing symptoms and preventing complications. This may include:
* Orthopedic interventions to correct skeletal abnormalities or treat fractures
* Dental care to address dental abnormalities and prevent tooth decay
* Speech therapy to help with any speech difficulties caused by the narrow mouth and high-arched palate
* Genetic counseling for affected individuals and their families.
Intermediate filament proteins (IFPs) are a type of cytoskeletal protein that form the intermediate filaments (IFs), which are one of the three major components of the cytoskeleton in eukaryotic cells, along with microtubules and microfilaments. These proteins have a unique structure, characterized by an alpha-helical rod domain flanked by non-helical head and tail domains.
Intermediate filament proteins are classified into six major types based on their amino acid sequence: Type I (acidic) and Type II (basic) keratins, Type III (desmin, vimentin, glial fibrillary acidic protein, and peripherin), Type IV (neurofilaments), Type V (lamins), and Type VI (nestin). Each type of IFP has a distinct pattern of expression in different tissues and cell types.
Intermediate filament proteins play important roles in maintaining the structural integrity and mechanical strength of cells, providing resilience to mechanical stress, and regulating various cellular processes such as cell division, migration, and signal transduction. Mutations in IFP genes have been associated with several human diseases, including cancer, neurodegenerative disorders, and genetic skin fragility disorders.
Maxillofacial abnormalities, also known as craniofacial anomalies, refer to a broad range of structural and functional disorders that affect the development of the skull, face, jaws, and related soft tissues. These abnormalities can result from genetic factors, environmental influences, or a combination of both. They can vary in severity, from minor cosmetic issues to significant impairments of vital functions such as breathing, speaking, and eating.
Examples of maxillofacial abnormalities include cleft lip and palate, craniosynostosis (premature fusion of the skull bones), hemifacial microsomia (underdevelopment of one side of the face), and various other congenital anomalies. These conditions may require multidisciplinary treatment involving surgeons, orthodontists, speech therapists, and other healthcare professionals to address both functional and aesthetic concerns.
Cranial fontanelles, also known as "soft spots," are the membrane-covered spaces between the bones of a newborn or infant's skull. There are six fontanelles in total: two anterior (frontal) fontanelles, two posterior (occipital) fontanelles, and two smaller sphenoid and mastoid fontanelles.
The anterior fontanelle is the most prominent and is located towards the front of the head. It typically measures about 1 to 2 inches in diameter at birth and closes by around 18-24 months of age as the bones of the skull grow together. The posterior fontanelle is smaller, located towards the back of the head, and usually closes by around 2 months of age.
The fontanelles allow for the baby's brain to grow rapidly during the first few months of life, and they also provide some flexibility during childbirth, allowing the skull bones to overlap and make it easier for the baby to pass through the birth canal. It is important to handle a newborn gently, especially around the fontanelles, as they are still developing and can be injured easily.
X-linked Ichthyosis is a genetic skin disorder that is caused by a deficiency of an enzyme called steroid sulfatase. This enzyme is needed to break down cholesterol sulfate in the skin, and its absence leads to the accumulation of cholesterol sulfate, which disrupts the normal process of skin cell shedding.
The symptoms of X-linked Ichthyosis typically appear at birth or within the first few weeks of life and include:
* Dry, scaly skin that is darker in color than the surrounding skin (hyperkeratosis)
* A buildup of scales on the skin, especially on the back, buttocks, and extremities
* Deep, thick creases on the palms of the hands and soles of the feet
* White scaling on the scalp, eyebrows, and eyelashes
* Increased vulnerability to skin infections
* Small white spots (called milia) on the nose and cheeks
* Affected newborns may also have difficulty closing their eyes due to the thickened skin around the eyelids.
The disorder is inherited through an X-linked recessive pattern, which means that it primarily affects males who inherit the affected gene from their mothers. Females who carry the gene can also be affected but are typically less severely so. There is no cure for X-linked Ichthyosis, but treatment is focused on managing symptoms and preventing complications.
Atopic dermatitis is a chronic, inflammatory skin condition that is commonly known as eczema. It is characterized by dry, itchy, and scaly patches on the skin that can become red, swollen, and cracked over time. The condition often affects the skin on the face, hands, feet, and behind the knees, and it can be triggered or worsened by exposure to certain allergens, irritants, stress, or changes in temperature and humidity. Atopic dermatitis is more common in people with a family history of allergies, such as asthma or hay fever, and it often begins in infancy or early childhood. The exact cause of atopic dermatitis is not fully understood, but it is thought to involve a combination of genetic and environmental factors that affect the immune system and the skin's ability to maintain a healthy barrier function.
Ichthyosiform erythroderma, congenital, also known as Congenital Ichthyosiform Erythroderma (CIE), is a rare inherited genetic disorder of keratinization. It is characterized by widespread scaliness and erythema (redness) that are present at birth or develop soon thereafter.
The condition is caused by mutations in various genes involved in the development of the skin barrier, leading to abnormalities in the formation and shedding of skin cells. This results in a thickened, scaly appearance of the skin, which can be associated with severe dryness, irritation, and inflammation.
The symptoms of CIE can vary widely among affected individuals, ranging from mild to severe. In addition to the characteristic skin changes, some people with CIE may also experience additional features such as ectropion (outward turning of the eyelids), eclabium (splitting of the lips), and hyperkeratosis of palms and soles.
CIE is typically a lifelong condition, and treatment is focused on managing symptoms and preventing complications. This may include the use of topical moisturizers, emollients, and keratolytic agents to help soften and remove excess skin cells. In some cases, systemic medications such as retinoids may be used to help reduce the severity of skin changes.
Proteus vulgaris is a species of Gram-negative, facultatively anaerobic, rod-shaped bacteria that are commonly found in soil, water, and the human digestive tract. They are named after the Greek god Proteus, who could change his shape at will, as these bacteria are known for their ability to undergo various morphological changes.
Proteus vulgaris is a member of the family Enterobacteriaceae and can cause opportunistic infections in humans, particularly in individuals with weakened immune systems or underlying medical conditions. They can cause a variety of infections, including urinary tract infections, wound infections, pneumonia, and bacteremia (bloodstream infections).
Proteus vulgaris is also known for its ability to produce urease, an enzyme that breaks down urea into ammonia and carbon dioxide. This can lead to the formation of urinary stones and contribute to the development of chronic urinary tract infections. Additionally, Proteus vulgaris can form biofilms, which can make it difficult to eradicate the bacteria from infected sites.
In a medical context, identifying Proteus vulgaris is important for determining appropriate antibiotic therapy and managing infections caused by this organism.
In medical terms, the skin is the largest organ of the human body. It consists of two main layers: the epidermis (outer layer) and dermis (inner layer), as well as accessory structures like hair follicles, sweat glands, and oil glands. The skin plays a crucial role in protecting us from external factors such as bacteria, viruses, and environmental hazards, while also regulating body temperature and enabling the sense of touch.
Stearyl-sulfatase is a type of enzyme that is responsible for breaking down certain types of fatty substances called lipids in the body. Specifically, it helps to break down a substance called stearyl sulfate, which is a type of sulfated lipid.
Stearyl-sulfatase is found in various tissues throughout the body, including the brain, skin, and kidneys. Mutations in the gene that provides instructions for making this enzyme can lead to a condition called X-linked ichthyosis, which is characterized by dry, scaly skin. This is because the body is unable to properly break down stearyl sulfate and other related lipids, leading to their accumulation in the skin.
In medical terminology, steruly-sulfatase may also be referred to as arylsulfatase C or Arylsulfatase-C.
'Desulfovibrio vulgaris' is a species of gram-negative, sulfate-reducing bacteria that is commonly found in aquatic environments, sediments, and the gastrointestinal tracts of animals. These bacteria are capable of reducing sulfates to sulfides, which can be toxic to other organisms and contribute to the formation of foul odors in certain environments. They are also able to use a variety of organic compounds as electron donors during this process, making them important players in the global sulfur cycle.
In medical contexts, 'Desulfovibrio vulgaris' is not typically considered a pathogen or cause of disease. However, there is some evidence to suggest that these bacteria may be associated with certain gastrointestinal disorders, such as inflammatory bowel disease (IBD) and colorectal cancer. This is because the sulfides produced by 'Desulfovibrio vulgaris' can be toxic to the cells lining the gut, leading to inflammation and damage.
It's worth noting that more research is needed to fully understand the role of 'Desulfovibrio vulgaris' in human health and disease. While these bacteria may contribute to certain gastrointestinal disorders, they are likely just one piece of a complex puzzle involving many different factors.
Epidermolytic hyperkeratosis (EH) is a rare genetic skin disorder characterized by the abnormal growth and accumulation of keratin, a protein found in the outermost layer of the skin (epidermis). This condition results in widespread blistering and peeling of the skin, particularly in areas prone to friction such as the hands, feet, knees, and elbows.
EH is caused by mutations in the KRT1 or KRT10 genes, which provide instructions for making keratin proteins that are essential for maintaining the structure and integrity of the epidermis. When these genes are mutated, the keratin proteins become unstable and form clumps, leading to the formation of blisters and areas of thickened, scaly skin (hyperkeratosis).
EH is typically present at birth or appears in early childhood, and it can range from mild to severe. In addition to the skin symptoms, individuals with EH may also experience nail abnormalities, hair loss, and an increased risk of skin infections. Treatment for EH is focused on managing symptoms and preventing complications, and may include topical creams or ointments, wound care, and protection from friction and injury.
Acne vulgaris is a common skin condition characterized by the formation of various types of blemishes on the skin, such as blackheads, whiteheads, papules, pustules, and cysts or nodules. These lesions typically appear on areas of the body that have a high concentration of sebaceous glands, including the face, neck, chest, back, and shoulders.
Acne vulgaris occurs when hair follicles become clogged with dead skin cells and excess oil (sebum) produced by the sebaceous glands. This blockage provides an ideal environment for bacteria, particularly Propionibacterium acnes, to multiply, leading to inflammation and infection. The severity of acne vulgaris can range from mild with only a few scattered comedones (blackheads or whiteheads) to severe cystic acne, which can cause significant scarring and emotional distress.
The exact causes of acne vulgaris are not fully understood, but several factors contribute to its development, including:
1. Hormonal changes during puberty, menstruation, pregnancy, or due to conditions like polycystic ovary syndrome (PCOS)
2. Genetic predisposition
3. Use of certain medications, such as corticosteroids and lithium
4. Excessive production of sebum due to overactive sebaceous glands
5. Accumulation of dead skin cells that clog pores
6. Bacterial infection (particularly Propionibacterium acnes)
7. Inflammation caused by the body's immune response to bacterial infection and clogged pores
Treatment for acne vulgaris depends on its severity and can include over-the-counter or prescription topical treatments, oral medications, chemical peels, light therapies, or even hormonal therapies in some cases. It is essential to seek professional medical advice from a dermatologist or healthcare provider to determine the most appropriate treatment plan for individual needs.
Ichthyosis vulgaris - Wikipedia
Ichthyosis vulgaris: Pictures, diagnosis, and treatment
Hereditary and Acquired Ichthyosis Vulgaris: Background, Pathophysiology, Etiology
Ichthyosis vulgaris | DermNet
ICHTHYOSIS VULGARIS - Ayur-Sudha
Ichthyosis vulgaris | Dermatology Oasis
ichthyosis vulgaris behandling - Med Norge
Skin Condition Remedies
Ingrown Hair Removal Treatment, Home Remedies, Types, Pictures
Skin Conditions | Hives | Acne | MedlinePlus
Indian Dermatology Online Journal
Han Lin - Articles - Scientific Research Publishing
Scaly signs in dermatology - Indian Journal of Dermatology, Venereology and Leprology
Atopic Dermatitis: Reasons for Optimism | MedPage Today
Skin Disease - Home Remedies, Causes, Symptoms, Treatment, Diet
Ichthyosis in Children | Lurie Children's
Would cast a pall?
Physical healing leads to new believers in Lesotho | Baptist Press
Salicylic Acid Monograph for Professionals - Drugs.com
Scaly Skin: 5 Causes And 5 Easy Care Tips | Skincare.com | Skincare.com
Major gene discovered that causes dry skin and leads to eczema and asthma | dreamhawk.com
Thieme E-Books & E-Journals - Journal of Pediatric Genetics / Issue
Ichthyosis acquisita - wikidoc